Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000486190 | SCV000569396 | pathogenic | not provided | 2022-06-03 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Genetic Services Laboratory, |
RCV000500968 | SCV000596657 | pathogenic | Warburg micro syndrome 1 | 2015-10-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004527590 | SCV004111789 | likely pathogenic | RAB3GAP1-related disorder | 2023-06-06 | criteria provided, single submitter | clinical testing | The RAB3GAP1 c.630_631insC variant is predicted to result in a frameshift and premature protein termination (p.Ile211Hisfs*17). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-135872933-T-TC). Frameshift variants in RAB3GAP1 are expected to be pathogenic. Therefore we interpret this variant as likely pathogenic. |